Marketing in the era of consumer-driven healthcare requires new tools and techniques. If you want patients to initiate therapy, you need to connect across more channels, more personally, and in the ways consumers prefer to be engaged. Plus, given today’s budget realities, you’re likely being asked to achieve more with less. In this podcast, William Grambley, CEO of AllazoHealth, explores how pharma marketers can reach their omni-channel engagement objectives with artificial intelligence (AI), anticipate patient intent and drive next-best-action at the individual level. With AI, pharma marketers can finally truly personalize campaigns, increase therapy initiation and medication adherence, and deliver marketing operations efficiency at scale.